XCSE
STENO
Market cap1mUSD
Apr 08, Last price
0.34DKK
1D
-16.75%
1Q
-62.44%
IPO
-99.05%
Name
Stenocare A/S
Chart & Performance
P/E
—
P/S
5.71
EPS
—
Div Yield, %
—
Shrs. gr., 5y
22.85%
Rev. gr., 5y
-23.97%
Revenues
2m
-40.60%
Net income
-34m
L+96.30%
CFO
-7m
L-28.88%
Profile
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 2,232 -40.60% | 3,758 -16.30% | 4,490 185.05% | ||||
Cost of revenue | 10,178 | 10,899 | |||||
Unusual Expense (Income) | |||||||
NOPBT | 2,232 | (6,420) | (6,410) | ||||
NOPBT Margin | 100.00% | ||||||
Operating Taxes | (108) | (1,253) | (1,584) | ||||
Tax Rate | |||||||
NOPAT | 2,340 | (5,167) | (4,825) | ||||
Net income | (34,488) 96.30% | (17,570) 7.77% | (16,303) 28.04% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 5,101 | 17,896 | |||||
BB yield | -13.93% | -50.53% | |||||
| Debt | |||||||
Debt current | 1,272 | 8,746 | 6,102 | ||||
Long-term debt | 3,394 | 2,311 | 6,479 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 13,220 | 1,053 | |||||
Net debt | 3,286 | 1,559 | 8,151 | ||||
| Cash flow | |||||||
Cash from operating activities | (7,141) | (10,041) | (15,033) | ||||
CAPEX | (44) | (176) | (936) | ||||
Cash from investing activities | (28) | (177) | (937) | ||||
Cash from financing activities | (949) | 15,287 | 8,679 | ||||
FCF | 14,851 | 492 | (6,391) | ||||
| Balance | |||||||
Cash | 1,381 | 9,498 | 4,429 | ||||
Long term investments | |||||||
Excess cash | 1,269 | 9,311 | 4,205 | ||||
Stockholders' equity | (2,674) | 25,822 | 24,143 | ||||
Invested Capital | 16,153 | 26,194 | 31,889 | ||||
ROIC | 11.05% | ||||||
ROCE | 16.56% | ||||||
| EV | |||||||
Common stock shares outstanding | 28,165 | 13,944 | 12,099 | ||||
Price | 1.30 -48.82% | 2.54 -72.36% | 9.19 -11.12% | ||||
Market cap | 36,615 3.38% | 35,418 -68.15% | 111,193 -11.04% | ||||
EV | 39,901 | 36,977 | 119,344 | ||||
EBITDA | 2,232 | (3,036) | (3,097) | ||||
EV/EBITDA | 17.88 | ||||||
Interest | 1,535 | 2,876 | 1,295 | ||||
Interest/NOPBT | 68.79% | ||||||